These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 2904755

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experience with doxazosin in general medical practice.
    Rosenthal J.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
    [Abstract] [Full Text] [Related]

  • 3. The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine.
    Lindner UK, von Manteuffel GE, Stafunsky M.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1814-20. PubMed ID: 2904756
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus.
    Castrignano R, D'Angelo A, Pati T, Al Awady M, Tronca R, Crepaldi G.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1778-84. PubMed ID: 2904750
    [Abstract] [Full Text] [Related]

  • 7. A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension.
    Taylor SH, Lee PS, Sharma SK.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1820-5. PubMed ID: 2904757
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A multicenter study of doxazosin in the treatment of severe essential hypertension.
    Soltero I, Guevara J, Silva H, Velasco M.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1767-71. PubMed ID: 2904748
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Ott P, Storm TL, Krusell LR, Jensen H, Badskjaer J, Faergeman O.
    Am J Cardiol; 1987 May 29; 59(14):73G-77G. PubMed ID: 2884856
    [Abstract] [Full Text] [Related]

  • 12. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
    Torvik D, Madsbu HP.
    Am J Cardiol; 1987 May 29; 59(14):68G-72G. PubMed ID: 2884855
    [Abstract] [Full Text] [Related]

  • 13. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B, Morgan TO, Gibson J, Anderson A.
    Drugs; 1987 May 29; 34 Suppl 3():109-19. PubMed ID: 2894971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN, Weidmann P, Riesen W, Claessens J, Streulens Y, Nelemans F.
    Am J Cardiol; 1987 May 29; 59(14):99G-104G. PubMed ID: 2884861
    [Abstract] [Full Text] [Related]

  • 18. [Randomized, comparative study to evaluate efficacy and safety of doxazosin versus nitrendipine in the treatment of mild to moderate hypertension].
    Sanz Guajardo D, Espejo Martínez J.
    An Med Interna; 1997 Jan 29; 14(1):15-9. PubMed ID: 9091027
    [Abstract] [Full Text] [Related]

  • 19. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT, Schonfeld G, Reeves RL, Black H, Weidler DJ.
    Am J Cardiol; 1987 May 29; 59(14):87G-90G. PubMed ID: 2884859
    [Abstract] [Full Text] [Related]

  • 20. A multicenter trial of doxazosin in West Germany.
    Rosenthal J.
    Am J Cardiol; 1987 May 29; 59(14):40G-45G. PubMed ID: 2884852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.